Quick answer
China has far more people waiting for a kidney than kidneys. Xenotransplantation — using gene-edited pigs — is one answer under development. Chen Gang's Institute of Organ Transplantation at Tongji Hospital reports that a macaque given a four-gene-edited pig kidney has now survived more than 600 days with normal renal function: last creatinine 94.8 μmol/L, no urinary albumin, good graft perfusion. That is an Asian record for primate xenotransplant survival, and puts the team alongside the two US groups that have passed two years [1][2][3].
Key takeaways
- Recipient: a macaque; graft: kidney from a four-gene-edited pig bred under standardised conditions [3].
- Survival beyond 600 days, with function normal at last measurement [1].
- The team expects the animal may exceed two years [1][3].
- Earlier in the programme, the same group reported China's first gene-edited pig-to-macaque kidney transplant surviving more than six months [5].
- Next step: initial clinical research within one to three years, after biosafety and ethics frameworks are completed [1].
Why cross-species kidneys are hard
Pig organs match human size and physiology better than any other animal's, but the immune reaction across species is violent — hyperacute rejection can destroy a graft within minutes. Gene editing removes the carbohydrate antigens that trigger it and adds human regulatory proteins; immunosuppression has to be tuned separately for the pig-macaque combination [1][3].
Long-term survival is the only convincing proof that the whole package — donor genetics, immunosuppression, infection control and coagulation management — works. Survival measured in days proves a graft can be implanted; survival past a year or two begins to prove it can replace a human organ [1][3].
What was reported
The donor pig carries four gene edits and was bred in a closed, standardised facility. Partners included Chengdu-based Zhongke Aoge, Hainan Medical University's second affiliated hospital and a pharmaceutical company supplying an investigational drug. The team describes a customised immunosuppressive regimen for xenotransplantation and a complete technical system, built on animal work dating back to a 1998 national 863 programme project [3][4].
This is one primate recipient, not a series, and it has not been published as a peer-reviewed trial in the sources reviewed. Long-term survival in macaques does not guarantee safety or efficacy in humans, where rejection, infection and physiological incompatibility may differ. The team itself frames the next step as initial clinical research in one to three years, pending biosafety and ethics approval [1][3].
The condition in context: organ shortage
Kidney failure is common, dialysis is burdensome and transplantation is limited by supply.
| Region | What the data shows | Source |
|---|---|---|
| China | 134,000 people were registered for a kidney transplant in 2023; fewer than one in nine received one [4]. | National Business Daily [4] |
| Worldwide | More than 150,000 solid-organ transplants were performed in 2022, less than a tenth of need [4]. | National Business Daily [4] |
| Primate benchmark | Only two US teams had previously kept xenotransplant primate recipients alive beyond two years [1][3]. | Tongji / Neijiang government [1][3] |
Because the waiting list grows faster than donation, a reliable pig source would change the arithmetic — which is why primate survival records attract attention [1][4].
Why it matters
| Potential | What the report suggests | Source |
|---|---|---|
| Supply | Gene-edited pigs could provide an unlimited, standardised organ source [1]. | [1] |
| Capability | China has moved from following to running alongside the US in preclinical xenotransplant [1][3]. | [1][3] |
| Caution | One primate, not peer-reviewed as a trial; human risk unknown [1]. | [1] |
Availability and limits
- This is an editorial summary of hospital and media reports, not a clinical service [1][2].
- No human xenotransplant is offered; clinical research is planned in one to three years [1].
- The result is a single primate recipient, not a controlled study [1].
- Infection risk from porcine viruses and long-term immunosuppression remain unsolved [3].
- Regulatory and ethics approval are prerequisites for any clinical use [1].
What to ask before booking
| Question | Why it matters |
|---|---|
| Am I eligible for a conventional transplant or a clinical trial? | Xenotransplant is not yet a clinical option [1]. |
| What is my position on the waiting list? | Human donation remains the standard route [4]. |
| Which department handles foreign patients, and in what language? | Tongji Hospital is a working hospital we do not book; confirm international-department coordination and language support. |
| Are any xenotransplant trials recruiting? | Clinical research is planned but not yet open [1]. |
Questions patients ask
What was achieved?
A macaque receiving a four-gene-edited pig kidney survived more than 600 days with normal renal function — an Asian record for primate xenotransplant survival [1][2].
Who led the work?
Chen Gang's Institute of Organ Transplantation at Tongji Hospital, with Zhongke Aoge and other partners [1][3].
Has this been done before?
Only two US teams have kept primate xenotransplant recipients alive beyond two years; this result places the Chinese team in the same league [1][3].
Can patients get a pig kidney now?
No — the team plans initial clinical research in one to three years, subject to biosafety and ethics approval [1].
Is this relevant to international patients?
It is context for the future of transplant supply. Tongji Hospital is a working hospital we do not book — contact its international department directly [1].